Experience and attitudes on vaccinations recommended during pregnancy: survey on an Italian sample of women and consultant gynecologists.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101572652 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2164-554X (Electronic) Linking ISSN: 21645515 NLM ISO Abbreviation: Hum Vaccin Immunother Subsets: MEDLINE
    • Publication Information:
      Publication: 2015- : Philadelphia, PA : Taylor & Francis
      Original Publication: Austin, Tex. : Landes Bioscience
    • Subject Terms:
    • Abstract:
      Active immunization in pregnancy is recommended for the influenza and the tetanus, diphtheria, and acellular pertussis (Tdap) vaccines. Evidence indicates vaccine effectiveness in preventing influenza-related hospitalizations and pertussis in early infancy. We investigate vaccine uptake in pregnant and non-pregnant women through a sample of young women and consultant gynecologists, along with the potential predisposing and/or enabling factors affecting attitudes to vaccination (knowledge, beliefs, barriers). A cross-sectional study was conducted between June and September 2019, with a sample of 251 women and 14 consultant gynecologists at the Local Health Authority (ASL01) of the Abruzzo Region (Italy), using an anonymous, self-report questionnaire survey. Among the participants, 5.6% of women had received influenza vaccination, 16.4% had received Tdap during pregnancy and only 1.2% had received both vaccines. The assessment of the psychometric attitudinal variables has suggested a more positive willingness to receive Tdap than influenza vaccine among women, as the former is considered more important for the maternal and neonatal health. Health care workers have reported vaccine safety concerns, lack of information, and misconceptions about the need for vaccination as barriers to immunization in pregnant women. The results of this study will contribute to defining the goals and strategies to increase vaccine uptake under the current recommendations, through promoting effective training programs for all health care workers involved (gynecologists, obstetricians, public health physicians).
    • References:
      BMC Infect Dis. 2020 Feb 13;20(1):136. (PMID: 32054444)
      J Matern Fetal Neonatal Med. 2021 Jul;34(13):2132-2139. (PMID: 31456459)
      Vaccine. 2017 Apr 25;35(18):2279-2287. (PMID: 28343772)
      J Pediatr. 2017 Aug;187:234-239.e4. (PMID: 28550954)
      Pediatrics. 2016 Jun;137(6):. (PMID: 27244843)
      BMC Infect Dis. 2017 Jan 9;17(1):48. (PMID: 28068918)
      Horm Behav. 2012 Aug;62(3):263-71. (PMID: 22406114)
      Hum Vaccin Immunother. 2017 Jan 2;13(1):198-205. (PMID: 27624736)
      Hum Vaccin Immunother. 2020 May 3;16(5):1093-1100. (PMID: 31725346)
      Am J Epidemiol. 1998 Dec 1;148(11):1094-102. (PMID: 9850132)
      Public Health. 2020 Feb;179:38-44. (PMID: 31726399)
      Hum Vaccin Immunother. 2016 Aug 2;12(8):1982-1988. (PMID: 27712242)
      Obstet Gynecol. 2012 Sep;120(3):532-7. (PMID: 22914461)
      BMC Cardiovasc Disord. 2019 Dec 2;19(1):277. (PMID: 31791237)
      Vaccine. 2016 Feb 10;34(7):968-73. (PMID: 26765288)
      Vaccine. 2015 Apr 27;33(18):2125-31. (PMID: 25796339)
      BMJ Open. 2016 Apr 06;6(4):e010386. (PMID: 27053270)
      Acta Obstet Gynecol Scand. 2015 Aug;94(8):797-819. (PMID: 26012384)
      Vaccine. 2015 May 5;33(19):2240-2247. (PMID: 25820060)
      Hum Vaccin Immunother. 2018 Jul 3;14(7):1573-1579. (PMID: 29863958)
      Int J Environ Res Public Health. 2019 Nov 15;16(22):. (PMID: 31731820)
      Birth Defects Res. 2020 Mar;112(5):393-403. (PMID: 31903700)
      J Med Microbiol. 2018 Oct;67(10):1426-1456. (PMID: 30222536)
      BMJ. 2011 Jun 14;342:d3214. (PMID: 21672992)
      J Infect Dis. 2011 May 1;203(9):1301-8. (PMID: 21459817)
      Front Public Health. 2020 Apr 22;8:120. (PMID: 32426313)
      Obstet Gynecol. 2012 Mar;119(3):631-9. (PMID: 22353963)
      Ann Intern Med. 2011 Dec 6;155(11):733-41. (PMID: 22147712)
      J Prev Med Hyg. 2019 Mar 29;60(1):E12-E17. (PMID: 31041405)
      Vaccine. 2015 Sep 11;33(38):4850-7. (PMID: 26238723)
      Ann Med. 2018 May;50(3):193-208. (PMID: 29308916)
      N Engl J Med. 2014 Jun 5;370(23):2211-8. (PMID: 24897084)
      Infection. 2017 Apr;45(2):171-178. (PMID: 27614887)
      Vaccine. 2018 Jul 16;36(30):4548-4554. (PMID: 29907484)
      J Matern Fetal Neonatal Med. 2016 Oct;29(19):3147-50. (PMID: 26555821)
      MMWR Morb Mortal Wkly Rep. 2019 Oct 11;68(40):885-892. (PMID: 31600186)
      Infect Dis (Auckl). 2020 Feb 10;13:1178633720904099. (PMID: 32095076)
      Ital J Pediatr. 2019 Apr 11;45(1):47. (PMID: 30975224)
      Minerva Ginecol. 2019 Aug;71(4):288-297. (PMID: 30938116)
      BMC Health Serv Res. 2019 Sep 2;19(1):616. (PMID: 31477095)
      Hum Vaccin Immunother. 2018;14(9):2183-2188. (PMID: 30024822)
    • Contributed Indexing:
      Keywords: Tdap; Vaccinations; attitudes; influenza vaccine; pregnancy
    • Accession Number:
      0 (Diphtheria-Tetanus-acellular Pertussis Vaccines)
      0 (Influenza Vaccines)
      0 (Pertussis Vaccine)
    • Publication Date:
      Date Created: 20210506 Date Completed: 20220418 Latest Revision: 20220418
    • Publication Date:
      20240104
    • Accession Number:
      PMC8920149
    • Accession Number:
      10.1080/21645515.2021.1894061
    • Accession Number:
      33956557